Benlysta

- Phase 2 trials showed the drug was safe, well tolerated and produced clinically relevant biological activity http://www.hgsi.com/belimumab.html
- Discovered: July 1994
- Developed by: Human Genome Sciences and GlaxoSmithKline
- Common uses: Treatment of lupus, rheumatoid arthritis and autoimmune diseases
- Generic name: Belimumab
- Also known as: LymphoStat-B
- Phase 3 trails approved by the FDA in October of 2006 http://www.hgsi.com/belimumab.html
- Works to suppress the B-lymphocyte stimulator, an antibody that attacks the body's healthy tissues http://www.hgsi.com/belimumab.html

view more fast facts...

Benlysta is an experimental prescription drug that controls the immune system to help lupus patients. The drug was in clinical tests as of July 20, 2009, but said to be working as intended.
Disclaimer

The content in this page is not a substitute for professional medical advice. Please contact your doctor before taking Benlysta.

Benlysta News
- Human Genome Begins Trial - Analyst Blog
  
  Hence the company's prime focus is towards the commercialization of its two lead drugs, Benlysta (belimumab), being developed with glaxosmithkline (GSK) for ... (November 25, 2009)
  Benzinga
- Lupus drug Benlysta passes second crucial test
  
  Benlysta, a new drug designed specifically to treat systemic lupus erythematosus, commonly called simply lupus, has passed a second clinical trial, ... (November 02, 2009)
  Los Angeles Times
- Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN™
  
  The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, BENLYSTA™ (belimumab) for lupus and ZALBIN™ (albinterferon ... (November 25, 2009)
  WELT ONLINE
- Glaxo sees Benlysta as "very major" opportunity
  
  L: Quote, Profile, Research, Stock Buzz) said on Thursday it expects its experimental lupus drug Benlysta to be a "very major" product and contribute ... (November 12, 2009)
  Reuters
view more news...
Benlysta Images Powered by Flickr and Google
Benlysta Links Powered by Google
- Lupus drug Benlysta shows promise, company says - USATODAY.com
  usatoday.com
- Positive Long-Term Data For BENLYSTA (formerly LYMPHOSTAT-B(R)) In ...
  
  Human Genome Sciences (HGS) has reported continuation data from a Phase II study of BENLYSTA™ (belimumab, formerly LymphoStat-B®) showing sustained improvement in patient...
  medicalnewstoday.com
- Lupus Drug Benlysta Effective In Phase 3 Trials
  
  In what has been described as the first lupus drug in decades to show effectiveness in phase 3 clinical trials, the announcement that Benlysta (belimumab) outperformed placebo has ...
  medicalnewstoday.com
- Human Genome Sciences Reports Positive Long-Term Data For Benlysta ...
  
  Human Genome Sciences Reports Positive Long-Term Data For Benlysta (Formerly Lymphostat-B) In Patients With Active Systemic Lupus Erythematosus - Drugs.com MedNews
  drugs.com
- BENLYSTA™ (belimumab, formerly LymphoStat-B®) - HGS
  
  Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.
  hgsi.com
view more links...
Benlysta Videos Powered by YouTube
Benlysta Blogs
- Knights of the Pain Table » New Lupus Medication, Benlysta, by ...
  
  The anticipated study data, from a clinical program called Bliss-76, showed a 10-milligram dose of Benlysta, plus therapy with steroids, prompted an improvement in 43 percent of patients, compared with an improvement in only 33 perce... (November 03, 2009)
  knightsofthepaintable.com
- 710.0: A Life With Lupus: Benlysta
  
  I was myself involved in a trial two years ago of a different medication, not this new Benlysta. My med has helped some lupus patients who have tried it but it didn't make the primary endpoint in the study...although the drug is bein... (November 11, 2009)
  710lupuslife.blogspot.com
- Lupus Research Institute: Benlysta(TM) Trial Results in an ...
  
  Second successful phase III trial points to the first new lupus tre...NEW YORK Nov. 2 -- The Lupus Research Institu... This is a pivotal moment in lupus research said Margaret G. Dowd p... This is spectacular news for the world-wide ... (November 02, 2009)
  bio-medicine.org
- Lupus Drug Benlysta by Human Genome Sciences and GlaxoSmithKline ...
  
  Human Genome Sciences (NASDAQ:HGSI) and GlaxoSmithKline PLC (NYSE:GSK) announced Monday morning that BENLYSTA met the primary endpoint in the second of two Phase 3 trials in seropositive patients with systemic lupus erythematosus. .... (November 02, 2009)
  ceoworld.biz
view more blogs...

ask any question

On Twitter Powered by Twitter
- Don't forget about our upcoming web event on Monday, November 30th. Learn more about the new drug BENLYSTA. See our... http://bit.ly/4JJkAM
- if you want to see how pharm research works, what the U.S> spends & my experiences in the Benlysta trials http://wolfbittink.blogspot.com/
- RT @joeyotto: Interesting press on Benlysta http://bit.ly/4jkBQl #lupus
- RT @WolfBitTink: the paper will be posted on my blog as soon as it's done & might give a glimpse of the possible benefits of BenLysta fo ...
- the paper will be posted on my blog as soon as it's done & might give a glimpse of the possible benefits of BenLysta for lupus patients
view more tweets...
Related Mahalo Pages

Lupus | Human Genome Sciences | GlaxoSmithKline | Rheumatoid Arthritis